UB Paderborn / Katalog / Suche / in CDI

26 – 47 von 47

Sortiert nach

The PROCEM study protocol: Added value of preoperative contrast-enhanced mammography in staging of malignant breast lesions - a prospective randomized multicenter study

BMC cancer, 2021-10, Vol.21 (1), p.1115-1115, Article 1115

2021

Volltextzugriff (PDF)

Remarkable similarities of chromosomal rearrangements between primary human breast cancers and matched distant metastases as revealed by whole-genome sequencing

Oncotarget, 2015-11, Vol.6 (35), p.37169-37184

2015

Volltextzugriff (PDF)

Proteogenomics decodes the evolution of human ipsilateral breast cancer

Communications biology, 2023, Vol.6 (1), p.139-139, Article 139

2023

Volltextzugriff (PDF)

Cancer associated proteins in blood plasma: Determining normal variation

Proteomics (Weinheim), 2016-07, Vol.16 (13), p.1928-1937

2016

Volltextzugriff (PDF)

Abstract PD6-10: A high ratio of CD8/FOXP3 predicts an unfavorable response to postoperative radiotherapy after breast-conserving surgery: Results from the randomized SweBCG91RT trial

Cancer research (Chicago, Ill.), 2020-02, Vol.80 (4_Supplement), p.PD6-10-PD6-10

2020

Volltextzugriff (PDF)

Stem cell biomarker ALDH1A1 in breast cancer shows an association with prognosis and clinicopathological variables that is highly cut-off dependent

Journal of clinical pathology, 2015-12, Vol.68 (12), p.1012-1019

2015

Volltextzugriff (PDF)

Correction to: Molecular analyses of triple-negative breast cancer in the young and elderly

Breast cancer research : BCR, 2021-02, Vol.23 (1), p.28-28, Article 28

2021

Volltextzugriff (PDF)

Gene expression profiling in primary breast cancer distinguishes patients developing local recurrence after breast-conservation surgery, with or without postoperative radiotherapy

Breast cancer research : BCR, 2008-01, Vol.10 (2), p.R34-R34, Article R34

2008

Volltextzugriff (PDF)

Added value of contrast-enhanced mammography (CEM) in staging of malignant breast lesions-a feasibility study

World journal of surgical oncology, 2020-05, Vol.18 (1), p.100-100, Article 100

2020

Volltextzugriff (PDF)

Localization of tamoxifen in human breast cancer tumors by MALDI mass spectrometry imaging

Clinical and translational medicine, 2016-03, Vol.5 (1), p.1-8

2016

Volltextzugriff (PDF)

Abstract P4-02-23: Integrating tumor-intrinsic and immunological factors to improve locoregional treatment individualization of high-risk breast tumors

Cancer research (Chicago, Ill.), 2023-03, Vol.83 (5_Supplement), p.P4-P4-02-23

2023

Volltextzugriff (PDF)

A somatic mutation in moesin drives progression into acute myeloid leukemia

Science advances, 2022-04, Vol.8 (16), p.eabm9987-eabm9987

2022

Volltextzugriff (PDF)

Abstract 5471: Integrating tumor-intrinsic and immunological factors to identify immunogenic breast cancers from a low-risk cohort; results from the randomized SweBCG91RT trial

Cancer research (Chicago, Ill.), 2023-04, Vol.83 (7_Supplement), p.5471-5471

2023

Volltextzugriff (PDF)

Gene expression profilers and conventional clinical markers to predict distant recurrences for premenopausal breast cancer patients after adjuvant chemotherapy

European journal of cancer (1990), 2006-11, Vol.42 (16), p.2729-2737

2006

Volltextzugriff (PDF)

Changes in glycoprotein expression between primary breast tumour and synchronous lymph node metastases or asynchronous distant metastases

Clinical proteomics, 2015-05, Vol.12 (1), p.13-13, Article 13

2015

Volltextzugriff (PDF)

A Targeted Mass Spectrometry Strategy for Developing Proteomic Biomarkers: A Case Study of Epithelial Ovarian Cancer

Molecular & cellular proteomics, 2019-09, Vol.18 (9), p.1836

2019

Volltextzugriff (PDF)

Localization of Tamoxifen in Human Breast Tumor by MALDI Mass Spectrometry Imaging

Clinical and translational medicine, 2016, Vol.5 (1)

2016

Volltextzugriff (PDF)

Proteomic analysis identifies candidate proteins associated with distant recurrences in breast cancer after adjuvant chemotherapy

Journal of pharmaceutical and biomedical analysis, 2007-02, Vol.43 (3), p.1086-1093

2007

Volltextzugriff (PDF)

Whole genome sequencing of primary breast cancers and matched distant metastases

American Association for Cancer Research (AACR) 106th Annual Meeting 2015,Philadelphia, United States,2015-04-18 - 2015-04-22, 2015, Vol.75 (15)

2015

Volltextzugriff (PDF)

Abstract 4805: Whole genome sequencing of primary breast cancers and matched distant metastases

Cancer research (Chicago, Ill.), 2015-08, Vol.75 (15_Supplement), p.4805-4805

2015

Volltextzugriff (PDF)

Cyclin B1 Is an Independent Prognostic Proliferation Marker with a High Reproducibility in a Population-Based Lymph Node Negative Breast Cancer Cohort

32nd Annual San Antonio Breast Cancer Symposium,San Antonio, TX, United States,2009-12-09 - 2009-12-13, 2009, Vol.69 (24_Supplement), p.6051-6051

2009

Volltextzugriff (PDF)

Amplification of the cyclin D1 gene is associated with tumour subsite, DNA non-diploidy and high S-phase fraction in squamous cell carcinoma of the head and neck

Oral oncology, 2004-07, Vol.40 (6), p.624-629

2004

Volltextzugriff (PDF)

Tumor-infiltrating lymphocytes in ipsilateral breast tumor recurrences predict prognosis

Journal of clinical oncology, 2020-05, Vol.38 (15_suppl), p.546-546

2020

Volltextzugriff (PDF)

26 – 47 von 47

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(46)
Mit Volltextzugriff
(45)

Publikationsform

Artikel
(45)
Tagungsberichte
(2)

Sprache

Englisch
(47)
Japanisch
(4)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

The PROCEM study protocol: Added value of preoperative contrast-enhanced mammography in staging of malignant breast lesions - a prospective randomized multicenter study

Remarkable similarities of chromosomal rearrangements between primary human breast cancers and matched distant metastases as revealed by whole-genome sequencing

Proteogenomics decodes the evolution of human ipsilateral breast cancer

Cancer associated proteins in blood plasma: Determining normal variation

Abstract PD6-10: A high ratio of CD8/FOXP3 predicts an unfavorable response to postoperative radiotherapy after breast-conserving surgery: Results from the randomized SweBCG91RT trial

Stem cell biomarker ALDH1A1 in breast cancer shows an association with prognosis and clinicopathological variables that is highly cut-off dependent

Correction to: Molecular analyses of triple-negative breast cancer in the young and elderly

Gene expression profiling in primary breast cancer distinguishes patients developing local recurrence after breast-conservation surgery, with or without postoperative radiotherapy

Added value of contrast-enhanced mammography (CEM) in staging of malignant breast lesions-a feasibility study

Localization of tamoxifen in human breast cancer tumors by MALDI mass spectrometry imaging

Abstract P4-02-23: Integrating tumor-intrinsic and immunological factors to improve locoregional treatment individualization of high-risk breast tumors

A somatic mutation in moesin drives progression into acute myeloid leukemia

Abstract 5471: Integrating tumor-intrinsic and immunological factors to identify immunogenic breast cancers from a low-risk cohort; results from the randomized SweBCG91RT trial

Gene expression profilers and conventional clinical markers to predict distant recurrences for premenopausal breast cancer patients after adjuvant chemotherapy

Changes in glycoprotein expression between primary breast tumour and synchronous lymph node metastases or asynchronous distant metastases

A Targeted Mass Spectrometry Strategy for Developing Proteomic Biomarkers: A Case Study of Epithelial Ovarian Cancer

Localization of Tamoxifen in Human Breast Tumor by MALDI Mass Spectrometry Imaging

Proteomic analysis identifies candidate proteins associated with distant recurrences in breast cancer after adjuvant chemotherapy

Whole genome sequencing of primary breast cancers and matched distant metastases

Abstract 4805: Whole genome sequencing of primary breast cancers and matched distant metastases

Cyclin B1 Is an Independent Prognostic Proliferation Marker with a High Reproducibility in a Population-Based Lymph Node Negative Breast Cancer Cohort

Amplification of the cyclin D1 gene is associated with tumour subsite, DNA non-diploidy and high S-phase fraction in squamous cell carcinoma of the head and neck

Tumor-infiltrating lymphocytes in ipsilateral breast tumor recurrences predict prognosis

Suchergebnisse filtern